In order to understand the biological properties of the immune systems of waterfowl and to establish a system for structural studies of duck class I major histocompatibility complex (DuMHC I), a complex of DuMHC I with duck 2 -microglobulin (Du 2 m) and the peptide AEIEDLIF (AF8) derived from H5N1 NP residues 251-258 was assembled. The complex was crystallized; the crystals belonged to space group C222 1 , with unit-cell parameters a = 54.7, b = 72.4, c = 102.2 Å , and diffracted to 2.3 Å resolution. Matthews coefficient calculation and initial structure determination by molecular replacement showed that the crystals did not contain the whole DuMHC I complex, but instead contained the DuMHC I 3 domain and a Du2m molecule (DuMHC I 3+2m). Another complex of DuMHC I with the peptide IDWFDGKE derived from a chicken fusion protein also generated the same results. The stable structure of DuMHC I 3+2m may reflect some unique characteristics of DuMHC I and pave the way for novel MHC structure-related studies in the future.
Introduction
The largest waterfowl-breeding industry in China involves the duck, with a population of up to 20-30 billion per year. Moreover, wild ducks, as well as other aquatic birds, are a natural reservoir of influenza type A viruses and play an important role in the ecology and propagation of these viruses. Virus representatives of all 16 haemagglutinin (HA) and all nine neuraminidase (NA) subtypes have been isolated from waterfowl (Sturm-Ramirez et al., 2005) . Previous studies have shown that the H5N1 avian influenza virus (AIV) only causes asymptomatic or low-pathogenic infections in ducks (Perkins & Swayne, 2002) . However, more and more evidence supports the facts that ducks not only show high susceptibility to H5N1 but also transmit the virus to other avian and mammalian hosts, including humans, and can cause outbreaks of severe disease (Perkins & Swayne, 2002; Zhou et al., 2006) . Therefore, further investigations into the immune system of ducks is needed, especially regarding the cellular immune response.
Major histocompatibility complex (MHC) class I molecules are critical for immune defences against viruses. These proteins present antigenic peptides to specific T-cell receptors (TCRs) on CD8 + T cells, resulting in the activation of cytotoxic lymphocytes (CTL) and the subsequent lysis of target cells (Bjorkman & Parham, 1990; Garboczi et al., 1996) . The MHC I complex contains a heavy chain and a light chain. The heavy chain is comprised of 1, 2 and 3 domains, all of which have an approximate molecular weight of 11 kDa. The light chain (also called 2 -microglobulin; 2 m) is a member of the immunoglobulin superfamily with a molecular weight of 12 kDa. The reported crystal structures of MHC I reveal that the 1 and 2 domains together form a peptide-binding groove, with two -helices at the top and an eight-stranded -sheet at the bottom. The 3 domain noncovalently associates with 2 m beneath the 1/2 domains (Saper et al., 1991; Koch et al., 2007) .
Little was known about the duck MHC class I molecule (DuMHC I) until its cDNA sequence was reported in 2004 (Xia et al., 2004) . Further studies have demonstrated that ducks predominantly express one MHC class I gene (Moon et al., 2005) . However, structural analysis of DuMHC I has not yet been reported. In this article, we describe the expression, refolding and crystallization of the duck MHC class I molecule in order to obtain a better understanding of the biological properties of the waterfowl immune system. The diffraction data that we obtained from the MHC I crystal unveiled some unique characteristics of the duck MHC class I molecule which deserve further attention.
Material and methods

Preparation of DuMHC I and Dub 2 m as inclusion bodies
The expression vectors pET21a(+)-DuMHC I (GenBank accession No. AB115245, residues 1-270) and pET21a(+)-Du 2 m (GenBank accession No. AB246408, residues 1-98) were constructed previously in the laboratory and transformed into Escherichia coli strain BL21 (DE3). The recombinant proteins were both expressed as inclusion bodies. The bacteria were harvested and suspended in cold phosphate-buffered saline (PBS). After sonication, the sample was centrifuged at 20 000g and the pellets were washed three times with a solution consisting of 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 mM DTT and 0.5% Triton X-100. DuMHC I and Du 2 m inclusion bodies were dissolved in guanidinium chloride (Gua-HCl) buffer [6 M Gua-HCl, 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 10 mM EDTA, 10%(v/v) glycerine, 10 mM DTT].
Refolding of the DuMHC I complex
The preparation of the DuMHC I-AF8-2 m complex was carried out essentially as described previously by Garboczi et al. (1992) with modifications introduced in our laboratory (Zhou et al., 2004; Chu et al., 2005) . The synthetically prepared H5N1-derived peptide AF8 (AEIEDLIF) was dissolved in dimethyl sulfoxide (DMSO). DuMHC I, Du 2 m and AF8 in a 1:1:3 molar ratio were refolded using the gradual solution method. After incubation for 48 h at 277 K, the remaining soluble portion of the complex was concentrated and then purified by chromatography on a Superdex 200 16/60 HiLoad (GE Healthcare) size-exclusion column followed by Resource Q (GE Healthcare) anion-exchange chromatography under nonreducing conditions.
Crystallization of the DuMHC I complex
The purified protein complex (45 kDa) was dialyzed against crystallization buffer (10 mM Tris-HCl pH 8.0, 10 mM NaCl) and concentrated to 15 mg ml À1 . Crystallization trials were set up with PEG/ Ion screen (Hampton Research) at 291 K using the hanging-drop method. Three drops containing equal volumes (1 ml each) of protein solution (at 5, 10 and 15 mg ml
À1
) and reservoir crystallization buffer were placed over a well containing 200 ml reservoir solution using a VDX plate (HR3-142; Hampton Research). Crystals were obtained in 5-7 d using solution No. 14 (0.2 M potassium thiocyanate, 12% PEG 3350 pH 7.0). The crystals obtained using a protein concentration of 10 mg ml À1 were suitable for data collection.
Data collection and processing
Data collection was performed in-house using a Rigaku MicroMax007 rotating-anode X-ray generator operated at 40 kV and 20 mA (Cu K; = 1.5418 Å ) and equipped with an R-AXIS VII ++ image-plate detector. The crystals were soaked for 20-30 s in reservoir solution supplemented with 20% glycerol as a cryoprotectant and then flash-cooled directly in liquid nitrogen. A complete data set was collected to 2.3 Å resolution. Data were indexed and scaled using DENZO and SCALEPACK (Otwinowski & Minor, 1997) . The Matthews coefficient and solvent content were calculated with MATTHEWS_COEF (Matthews, 1968; Collaborative Computational Project, Number 4, 1994) .
Results and discussion
Strategy of peptide design
The peptide-binding motif of duck MHC class I (DuMHC I) is not very clear. As both duck and chicken belong to the avian family, we tested the known peptide IE8 (IDWFDGKE) and a predicted peptide AF8 (AEIEDLIF from H5N1 NP residues 251-258) based on the peptide-binding motif of the chicken MHC class I molecule (Wallny et al., 2006) . Both peptides worked beautifully in refolding DuMHC I.
Refolding and purification of the DuMHC I complex
DuMHC I could be refolded in the presence of Du 2 m and peptide AF8. The refolding resulted in a yield of approximately 15% of the correctly folded complex, which could be purified to homogeneity by Superdex 200 16/60 HiLoad size-exclusion chromatography and Resource Q anion-exchange chromatography (Fig. 1) . The chroma- tographic profile showed a primary peak corresponding to the expected refolded complex (peak 1, 45 kDa; Fig. 1a ). The refolded complex was further purified by Resource Q chromatography and eluted at an NaCl concentration of 28.5-34.0% (Fig. 1b) . Subsequent reducing SDS-PAGE analysis showed two bands corresponding to the expected molecular weights of the heavy chain (33 kDa) and of 2 m (12 kDa).
Ideal crystals suitable for data collection
After purification and concentration, the DuMHC I complex protein was set up for crystal screening. Ideal crystals appeared in 5-7 d under the initial conditions (Fig. 2) . The crystals belonged to space group C222 1 , with unit-cell parameters a = 54.7, b = 72.4, c = 102.2 Å , and diffracted to 2.3 Å resolution. Data statistics are shown in Table 1 .
Initial structure determination
To determine the number of molecules per asymmetric unit, we calculated the Matthews coefficient, the solvent content and the molecular weight of the molecules in the unit cell. As the molecular weight of the DuMHC I complex is about 45 kDa, we found that the unit cell of the obtained crystal could not accommodate the whole DuMHC I complex.
Further molecular replacement (Collaborative Computational Project, Number 4, 1994) using different models, such as the complete MHC I complex, the heavy chain of MHC I only, 2 m only, the 1 and 2 domains of the heavy chain and the 3 domain of the heavy chain plus 2m, confirmed that the protein in the crystal was not the whole MHC class I molecule but consisted of 3+ 2 m (23 kDa). Based on this information, the solvent content was about 42% and the Matthews coefficient was 2.11 Å 3 Da À1 , which is reasonable. We also prepared DuMHC I protein using another peptide IE8 (IDWF-DGKE), derived from a chicken fusion protein, and obtained the same results.
The initial DuMHC I 3+ 2 m structure was determined by molecular replacement using MOLREP from the CCP4 package (Collaborative Computational Project, Number 4, 1994; Lebedev et al., 2008) with the structure of the chicken MHC class I molecule BF2*2101 (PDB code 3bev, with the peptide, 1 and 2 domains excluded; Koch et al., 2007) as the search model. Du 2 m was located first and the DuMHC I 3 domain was then found in a rotation-and translation-function search with Du 2 m fixed. The molecularreplacement solution had an initial R factor of 0.441 and a correlation coefficient of 0.603. In terms of the initial R factor and correlation coefficient, solution of the crystal structure of DuMHC I 3+2m has been achieved.
Unravelling the structural basis of the molecules involved in cellular immune responses is crucial for functional studies and drug/ vaccine design. Although the reason for the degradation of DuMHC I into its subparts (3+ 2 m) during crystallization is not clear, the stability of duck MHC I 3+ 2 m has been proved. After the final structure has been released, the contact characteristics of 3 and 2 m will be available, paving the way for novel MHC-structure related studies in the near future. Typical appearance of a crystal in the hanging drop. 
